期刊文献+

Prognostic performance of interleukin-10 in patients with chest pain and mild to moderate coronary artery lesions an 8-year follow-up study 被引量:8

Prognostic performance of interleukin-10 in patients with chest pain and mild to moderate coronary artery lesions an 8-year follow-up study
在线阅读 下载PDF
导出
摘要 Background Interleukin (IL)-10, IL-6 and their ratio (IL-6/IL-10) play an important role in the risk of developing coronary artery disease, and may correlate with its outcomes. Few clinical trials have investigated the prognostic impact of these factors on long-term car- diovascular events in patients presented with chest pain. Methods A prospective study was performed on 566 patients admitted with chest pain and identified mild to moderate coronary artery lesions. 1L-10, IL-6 and IL-6/IL-10 were measured. Results A total of 511 patients com- pleted the follow-up. The median follow-up time was 74 months. Kaplan-Meier analysis demonstrated a clear increase of the incidence of major adverse cardiac events during the follow-up period in patients with below-median levels of IL-10 (P = 0.006) and above-median levels of IL-6/IL-10 (P = 0.012). Multivariate Cox proportional hazards analysis indicated the IL-10 levels to be strong independent predictors after adjustment for underlying confounders. Conclusions Elevated IL-10 levels are associated with a more favorable long-term prognosis in patients with chest pain and mild to moderate coronary artery lesions. IL-10 could be used for early risk assessment of long-term prognosis.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2016年第3期244-251,共8页 老年心脏病学杂志(英文版)
关键词 Chest pain Coronary artery disease INTERLEUKIN-6 INTERLEUKIN-10 Prognosis 白细胞介素-10 冠状动脉疾病 患者 随访 病变 预测性能 疼痛 胸部
  • 相关文献

参考文献22

  • 1Mallat Z, Besnard S, Duriez M, et al. Protective role of inter- leukin-10 in atherosclerosis. Circ Res 1999; 85: e17-e24.
  • 2de Vries JE. Immunosuppressive and anti-inflammatory prop- erties ofinterleukin 10. ANNMED 1995; 27: 537-541.
  • 3Pinderski OL, Hedrick CC, Olvera T, et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol 1999; 19: 2847-2853.
  • 4Heeschen C, Dimmeler S, Hamm CW, et al. Serum level of the antiinflammatory cytokine interlettldn-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003; 107:2109-2114.
  • 5Schieffer B, Schieffer E, Hilfiker-Kleiner D, et al. Expression of angiotensin II and interleukin 6 in human coronary athero- sclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000; 101: 1372-1378.
  • 6Lindmark E, Diderholm E, Wallentin L, et al. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or nonin- vasive strategy. JAMA 2001; 286:2107-2113.
  • 7Little WC, Constantinescu M, Applegate R J, et al. Can coro- nary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988; 78:1157-1166.
  • 8Mallat Z, Besnard S, Duriez M, et al. Protective role of inter- lettldn-10 in atherosclerosis. Circ Res 1999; 85: e17--e24.
  • 9Pinderski OL, Hedrick CC, Olvera T, et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol.1999; 19: 2847-2853.
  • 10Pinderski L J, Fischbein MP, Subbanagounder G, et al. Over- expression of intefleukin-10 by activated T lymphocytes in- hibits atherosclerosis in LDL receptor-deficient mice by alter- ing lymphocyte and macrophage phenotypes. Circ Res 2002; 90: 1064-1071.

同被引文献60

引证文献8

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部